Synapse - Roisin O'Cearbhaill

Results (272)

A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies

Meeting Abstract

Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Somatic mutations in homologous recombination pathway genes in ovarian cancer

Meeting Abstract

Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013

Journal Article

Oseledchyk, A.; Leitao, M. M. Jr; Konner, J.; O'Cearbhaill, R. E.; Zamarin, D.; Sonoda, Y.; Gardner, G. J.; Roche, K. L.; Aghajanian, C. A.; Grisham, R. N.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer

Journal Article

Cowan, R. A.; O’Cearbhaill, R. E.; Zivanovic, O.; Chi, D. S.
International Journal of Hyperthermia (2017)

Fulltext@MSK | Save

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Journal Article

Sioulas, V. D.; Schiavone, M. B.; Kadouri, D.; Zivanovic, O.; Roche, K. L.; O'Cearbhaill, R.; Abu-Rustum, N. R.; Levine, D. A.; Sonoda, Y.; Gardner, G. J.; more...
Gynecologic Oncology (2017)

Fulltext@MSK | Save

Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC)

Meeting Abstract

O'Cearbhaill, R. E.; McMeekin, D. S.; Mantia-Smaldone, G.; Gunderson, C.; Sabbatini, P.; Cattaruzza, F.; Fischer, M.; Kapoun, A. M.; Xu, L.; Dupont, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center

Journal Article

Mueller, J. J.; Kelly, A.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Sonoda, Y.; O'Cearbhaill, R. E.; Zivanovic, O.; Chi, D. S.; Gardner, G. J.
Gynecologic Oncology (2016)

Fulltext@MSK | Save

Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center

Journal Article

Schlappe, B. A.; Mueller, J. J.; Zivanovic, O.; Gardner, G. J.; Roche, K. L.; Sonoda, Y.; Chi, D. S.; O'Cearbhaill, R. E.
Gynecologic Oncology (2016)

Fulltext@MSK | Save

A phase I study of unimolecular pentavalent (Globo-H-GM2-sTn-TF-Tn) immunization of patients with epithelial ovarian, fallopian tube, or peritoneal cancer in first remission